Sleep · Sleep peptide (research)
DSIP
- Drug class
- Sleep peptide (research)
- Status
- Compounded (503A)
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What DSIP is studied for
- Deep sleep support (research)
- Sleep architecture (research)
- Recovery (research)
Mechanism of action
DSIP is being studied in the sleep category. Delta Sleep-Inducing Peptide for deep sleep architecture. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is DSIP?
DSIP is a sleep peptide. Delta Sleep-Inducing Peptide for deep sleep architecture.
What is DSIP studied for?
Published research has examined DSIP for deep sleep support, sleep architecture, recovery. Human clinical evidence varies by indication.
Is DSIP FDA-approved?
No. DSIP is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is DSIP used in research?
Protocols vary by study. DSIP is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for DSIP is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.